Tirzepatide (Tirz) is a dual GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) receptor agonist designed for advanced research into metabolic health, weight management, and glucose regulation. Its dual-incretin mechanism enhances insulin secretion, improves insulin sensitivity, and reduces appetite, making it a highly valuable tool in preclinical studies on obesity and type 2 diabetes.

Research Applications & Potential Effects:

• Investigation of glucose regulation and insulin sensitivity

• Studies on weight loss and appetite suppression

• Evaluation of dual incretin pathway synergy in metabolic control

• Preclinical assessment of cardiovascular and lipid profile improvements

Supplied as a sterile, Lyophilised powder in liquid to ensure optimal stability and purity for precise research outcomes.

Molecular Formula: C225H348N48O68
Molar Mass: 4813.52 g/mol
Form: Lyophilised powder in liquid
Purity: ≥ 99% (HPLC)
Storage: Store at −20 °C, protect from light
Intended Use: Strictly for research purposes only. Not for human consumption, medical, or veterinary use.
CAS Number: 2023788-19-2